Palatin Technologies (NASDAQ:PTN – Free Report) – Investment analysts at HC Wainwright issued their Q1 2027 earnings per share estimates for Palatin Technologies in a research note issued to investors on Friday, November 6th. HC Wainwright analyst J. Pantginis anticipates that the company will earn ($0.32) per share for the quarter. HC Wainwright has a “Buy” rating and a $12.00 price objective on the stock. The consensus estimate for Palatin Technologies’ current full-year earnings is ($1.50) per share. HC Wainwright also issued estimates for Palatin Technologies’ Q2 2027 earnings at ($0.33) EPS, Q3 2027 earnings at ($0.34) EPS, Q4 2027 earnings at ($0.49) EPS and FY2027 earnings at ($1.50) EPS.
PTN has been the subject of a number of other reports. Weiss Ratings initiated coverage on shares of Palatin Technologies in a report on Wednesday, November 4th. They issued a “sell (e+)” rating for the company. Zacks Research began coverage on shares of Palatin Technologies in a report on Friday, November 6th. They set a “hold” rating on the stock. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Palatin Technologies has a consensus rating of “Hold” and an average price target of $12.00.
Palatin Technologies Stock Performance
PTN stock opened at $6.89 on Monday. Palatin Technologies has a one year low of $4.51 and a one year high of $31.00.
About Palatin Technologies
Palatin Technologies is a biopharmaceutical company that develops peptide-based medicines designed to act on specific receptors. Its research has focused primarily on the melanocortin system, which is involved in a range of biological functions and potential therapeutic applications. The company’s commercial product is Vyleesi (bremelanotide), an injectable prescription medicine approved in the United States to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.
Featured Articles
- Five stocks we like better than Palatin Technologies
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
